Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
Jiaping Li(Wannan Medical College), Yanhong Deng(Sun Yat-sen University), Minjie Luo(Children's Hospital of Philadelphia), Guan Wang(GenomiCare (China)), Jianwei Zhang(Capital Medical University), Chen Wang(Xiamen University), Jun Liu(Second Military Medical University), Zhan Wang(First Affiliated Hospital of Zhengzhou University), Jiping Wang, Wei Jiang(Tianjin Huanhu Hospital), Qiang Xu(Wannan Medical College), Jinwang Wei(GenomiCare (China)), Wending Sun(GenomiCare (China)), Linbo Cai(Guangdong 999 Brain Hospital), Chun Dai(Peking University), Shengzhou Wang(Genecast (China))
Cited by 39
Related Papers
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
|Cancer Cell|2018|1.2k
Pathogenic Germline Variants in 10,389 Adult Cancers
|Cell|2018|904
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|705
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456